Merck Serono Announces FDA Approval of Rebif® Rebidose® (interferon beta-1a)
GENEVA, January 3, 2013 /PRNewswire/ — Merck Serono, a division of Merck, Darmstadt, Germany, announced that the U.S. Food and Drug Administration (FDA) approved Rebif(R) Rebidose(R) (interferon beta-1a), a single-use …